PAA 6.67% 24.0¢ pharmaust limited

Ann: Epichem Awarded One-Year Contract Extension from DNDi, page-9

  1. 924 Posts.
    lightbulb Created with Sketch. 596
    To put it in perspective:

    2018 Epichem External Revenue $2,890,000 NPBT $10k
    2019 Epichem External Revenue $3,670,000 NPBT $390k
    2020 Epichem Forecast Revenue up $500k to $4.2m, now $3.3m

    The contract loss hurts our run but still trending ok. The non-renewed Unity contract of around $900k pa remains offset by about $500k of new 2020 work. I expect the main role of Epichem's new CEO's is to both diversify and boost total revenue. An early plus and minus ... too early to mark at the moment.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.015(6.67%)
Mkt cap ! $91.06M
Open High Low Value Volume
22.5¢ 24.0¢ 22.5¢ $113.7K 495.6K

Buyers (Bids)

No. Vol. Price($)
4 81166 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 112556 4
View Market Depth
Last trade - 14.39pm 17/06/2024 (20 minute delay) ?
Last
24.0¢
  Change
0.015 ( 6.67 %)
Open High Low Volume
22.5¢ 24.0¢ 22.5¢ 178550
Last updated 14.39pm 17/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.